MatthewLAndersonMDPhD

Obstetrics & Gynecology • Tampa, FL

Gynecologic Oncology

Professor, Gynecologic Oncology and Molecular Pharmacology & Physiology University of South Florida Morsani College of Medicine Associate Director for Shared Resources, Tampa General Hospital Cancer Institute

Join to view full profile

Dr. Anderson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Anderson's full profile

Already have an account?

Office
2 Tampa General Circle
Suite 6005 STC
Tampa, FL 33606
Phone+1 813-259-8512

Fax+1 813-259-8593

Education & Training

University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 1999 - 2002
Yale-New Haven Medical CenterResidency, Obstetrics and Gynecology, 1995 - 1999
Yale School of MedicineClass of 1995

Certifications & Licensure

TX State Medical License 2000 - 2026
FL State Medical License 2018 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Clinical Trials

A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Start of enrollment: 2020 Jul 23
Completed
Phase 3
Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers Start of enrollment: 2019 Feb 01
Active, not recruiting
Phase 1
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

Spatially restricted ecto-5'-nucleotidase expression promotes the growth of uterine leiomyomas by modulating Akt activity.
Xiaofang Guo, Maja Okuka, Brittney Short, Asli Ozmen, Nihan Semerci Gunay
FASEB Journal. 2024-10-15
Proteomic studies of VEGFR2 in human placentas reveal protein associations with preeclampsia, diabetes, gravidity, and labor.
Shannon J Ho, Dale Chaput, Rachel G Sinkey, Amanda H Garces, Erika P New
Cell Communication and Signaling. 2024-04-09
4 citations
Self-Sampling for Human Papillomavirus Testing: Acceptability in a U.S. Safety Net Health System.
Susan L Parker, Trisha L Amboree, Shaun Bulsara, Maria Daheri, Matthew L Anderson
American Journal of Preventive Medicine. 2024-03-01